Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glia limitans superficialis oxidation and breakdown promote cortical cell death after repetitive head injury
Hannah D. Mason, Alexis M. Johnson, Nicole A. Mihelson, Panagiotis Mastorakos, Dorian B. McGavern
Hannah D. Mason, Alexis M. Johnson, Nicole A. Mihelson, Panagiotis Mastorakos, Dorian B. McGavern
View: Text | PDF
Research Article Immunology Neuroscience

Glia limitans superficialis oxidation and breakdown promote cortical cell death after repetitive head injury

  • Text
  • PDF
Abstract

Repetitive mild traumatic brain injuries (mTBI) disrupt CNS barriers, the erosion of which has been linked to long-term neurodegenerative and psychiatric conditions. Although much attention has been devoted to CNS vasculature following mTBI, little is known about the glia limitans superficialis — a barrier of surface-associated astrocytes that helps protect the CNS parenchyma and maintain homeostasis. Here, we identify the glia limitans superficialis as a crucial barrier surface whose breakdown after acute repeat mTBI facilitates increased cell death and recruitment of peripheral myelomonocytic cells. Using intravital microscopy, we show that brain-resident microglia fortify this structure after a single mTBI, yet they fail to do so following secondary injury, which triggers massive recruitment of myelomonocytic cells from the periphery that contribute to further destruction of the glia limitans superficialis but not cortical cell death. We demonstrate, instead, that reactive oxygen species (ROS) generated in response to repetitive head injury are largely responsible for enhanced cortical cell death, and therapeutic administration of the antioxidant glutathione markedly reduces this cell death, preserves the glia limitans, and prevents myelomonocytic cells from entering the brain parenchyma. Collectively, our findings underscore the importance of preserving the glia limitans superficialis after brain injury and offer a therapeutic means to protect this structure and the underlying cortex.

Authors

Hannah D. Mason, Alexis M. Johnson, Nicole A. Mihelson, Panagiotis Mastorakos, Dorian B. McGavern

×

Figure 3

Reinjury promotes LFA-1/VLA-4–dependent recruitment of peripheral myelomonocytic cells.

Options: View larger image (or click on image) Download as PowerPoint
Reinjury promotes LFA-1/VLA-4–dependent recruitment of peripheral myelom...
(A) Representative xy (top) and xz (bottom) maximally projected Z stacks (180 μm in depth) show LysM-GFP+ myelomonocytic cells (green) and vasculature labeled with Evans blue (red) in LysMgfp/+ reporter mice with a single injury or with reinjury and treated with isotype control or αLFA-1/VLA-4 antibodies. See corresponding Supplemental Video 2. Images are representative of 8 independent experiments with 2–4 mice. Scale bars: 40 μm (top, xy) and 20 μm (bottom, xz). (B) Quantification of total LysM-GFP+ myelomonocytic cells in the meninges. (C) Quantification of total myelomonocytic cells in the parenchyma. Bar graphs are representative of 8 independent experiments with 1–4 mice per group. (D) Representative xz maximally projected Z stacks (300 μm in depth) of SR101 leakage (white) applied transcranially through the skull (green) in reinjury mice treated either with isotype or αLFA-1/αVLA-4 antibodies. Glia limitans superficialis depicted as red dashed line. Scale bar: 40 μm. (E) Quantification of SR101 leakage by MFI. (F) Representative xy maximally projected Z stacks (100 μm in depth) show PI-labeled dead cells (red) in reinjury mice treated either with isotype or αLFA-1/αVLA-4 antibodies. Scale bar: 100 μm. (G) Quantification of cell death by selecting only PI+DAPI+ cells. (B, C, E, and G) Bar graphs represent 2–4 independent, pooled experiments with 2–5 mice per group per experiment. Each symbol depicts an individual mouse. (B and C) Data represent raw myelomonocytic cell counts. (E and G) Data were normalized to average reinjury isotype per experimental day. All data in B, C, E, and G are displayed as the mean fold change ± SD with *P ≤ 0.05, and **P ≤ 0.01 using 2-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts